Aortic, Heart Valves and Outcomes - Cardiovascular Update

Patients Who Received Ross Procedure Demonstrate Excellent Survival Rates after 20 Years

Society of Thoracic Surgeons - Adult Cardiac

JANUARY 26, 2025

Dr. Shettys team followed 252 patients who underwent the Ross procedure, a heart valve replacement operation commonly used to treat younger patients with severe aortic valve disease. Freedom from aortic regurgitation was 95.1%, 92.2%, 87.7%, and 84.5% Shettys team found that survival rates were 95.8% at 20 years.

Aortic valve

Aortic valve Cardiothoracic Congenital Aortic

Case Report: A case of transcatheter aortic valve replacement in a patient with a small aortic annulus using the Acurate Neo2

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

Small aortic annulus poses a major challenge in aortic valve replacement due to the increased risk of prosthesispatient mismatch (PPM) and increased surgical risk. In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement.

Aortic valve

Aortic valve Aortic TAVR Myocardial Infarction

Predictors of permanent pacemaker requirement in aortic stenosis patients undergoing self-expanding valve transcatheter aortic valve replacement using the cusp overlap technique

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV). Forty-seven received SEVs using COL, and 50 with CON techniques.

Pacemaker

Pacemaker Aortic Stenosis Aortic valve

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

What Are the Implications of Choosing a TAVR-First Strategy in the Lifetime Management of Aortic Stenosis?: A Critical Review of TAVR-Explant- and Redo-TAVR

Circulation: Cardiovascular Interventions

JANUARY 22, 2025

Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many. If their transcatheter heart valve degenerates later in life, most will hope to undergo redo-TAVR.

TAVR

TAVR Aortic valve Aortic Stenosis

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

DAIC

FEBRUARY 18, 2025

Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heart valve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heart valve interventions will increase significantly in the coming decades.

Heart Valves

Heart Valves Quality of Life Cardiothoracic Outcomes

Direct aortic TAVI via anterior right mini-thoracotomy using 32 mm myval for pure aortic regurgitation

Journal of Cardiothoracic Surgery

AUGUST 29, 2024

Background Aortic regurgitation with dilated annulus presents a technical challenge for conventional transcatheter aortic valve implantation (TAVI) procedures. The patient recovered well post-operatively with good hemodynamic resolution.

Aortic

Aortic Aortic valve Heart Valves Innovation

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). Circulation: Cardiovascular Interventions, Ahead of Print. 2.44];P=0.035).

Aortic valve

Aortic valve Bicuspid/Mitral Aortic Tricuspid

TAVI in Patients With High-Risk Symptomatic Native AR

American College of Cardiology

APRIL 4, 2024

What are the outcomes with transfemoral transcatheter aortic valve implantation (TAVI) in patients with pure aortic regurgitation (AR) using the Trilogy transcatheter heart valve?

Aortic valve

Aortic valve Heart Valves Aortic Outcomes

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Reintervention for failed transcatheter heart valves will likely increase in the future as younger patients are expected to outlive the initial bioprosthesis.

Aortic valve

Aortic valve Aortic TAVR Heart Valves

Novel Real-Time Fluoroscopic Assessment Method of Transcatheter Heart Valve Expansion Following Balloon-Expandable TAVR

Circulation: Cardiovascular Interventions

JANUARY 24, 2025

BACKGROUND:Transcatheter heart valve (THV) underexpansion after transcatheter aortic valve replacement may be associated with worse outcomes. Circulation: Cardiovascular Interventions, Ahead of Print.

Heart Valves

Heart Valves Aortic valve TAVR Aortic

Redo Transcatheter Aortic Valve Implantation in the Lotus Mechanically Expanded Transcatheter Heart Valve: Bench-Top Analysis, Clinical Experience, and Procedural Guidance

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

BACKGROUND:Redo transcatheter aortic valve implantation (TAVI) is increasing as patients outlive their transcatheter heart valves (THVs) and present with bioprosthetic valve failure. Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013296, November 1, 2023.

Aortic valve

Aortic valve Heart Valves Aortic Cardiovascular Interventions

Time to TAVI: streamlining the pathway to treatment

Open Heart

SEPTEMBER 4, 2023

Introduction Severe aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. Methods The centre performing local workup implemented a novel TAVI referral pathway.

Heart Valves

Heart Valves Aortic valve Aortic Outpatient

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left?sided valvular heart disease in Europe. Insights from the ESC?EORP Valvular Heart Disease II survey

European Journal of Heart Failure

FEBRUARY 19, 2024

Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. ESC-EORP, European Society of Cardiology-EURObservational Research Programme; TV, tricuspid valve.

Tricuspid

Tricuspid Heart Disease Bicuspid/Mitral Heart Valves

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. Francis Hospital , and faculty member at Columbia University. Francis Hospital , and faculty member at Columbia University.

TAVR

TAVR Aortic valve Aortic Stenosis

Triumph in TAVI: Adana ?ehir Sa?l?k Uygulama ve Ara?t?rma Merkezi Hosts Successful Masterclass with Prof. Dr. Ibrahim Halil Kurt

ADN Center of Excellence

JANUARY 14, 2024

In the heart of Adana, the Adana Şehir Sağlık Uygulama ve Araştırma Merkezi recently became the epicenter of groundbreaking advancements in medical education. Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass.

Interventional Cardiology

Interventional Cardiology Education Heart Valves Aortic valve

Triumph in TAVI: Adana City Health Training and Research Center Hosts Successful Masterclass with Prof. Dr. Ibrahim Halil Kurt

ADN Center of Excellence

JANUARY 14, 2024

In the heart of Adana, the Adana City Health Training and Research Center recently became the epicenter of groundbreaking advancements in medical education. Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass.

Research

Research Education Heart Valves Aortic valve

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

DAIC

FEBRUARY 22, 2024

Photo courtesy of Mount Sinai Health System milla1cf Thu, 02/22/2024 - 13:47 February 22, 2024 — Ismail El-Hamamsy , MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mount Sinai Randall B.

Heart Valves

Heart Valves Aortic valve Aortic Sudden Cardiac Death

AHA Raises Awareness on HVD

DAIC

MARCH 4, 2025

22, 2025More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. This year on Heart Valve Disease Awareness Day (Feb. tim.hodson Tue, 03/04/2025 - 14:11 Feb.

Heart Valves

Heart Valves Aortic valve Aortic Stenosis

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management.

Aortic valve

Aortic valve Aortic Innovation Cardiothoracic

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. More specifically, the Avalus Ultra surgical valve has: A low valve profile designed to facilitate ease of use at implant.1,2

Aortic valve

Aortic valve Aortic Innovation Cardiothoracic

Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease

Heart BMJ

APRIL 15, 2024

This study aimed to analyse the aortic valve and root involvement in FLNA -MVD families and its impact on outcomes. Echocardiography was performed in 185 patients and histological analysis in 3 explanted aortic valves. The outcomes were defined as aortic valve surgery or all-cause mortality.

Bicuspid/Mitral

Bicuspid/Mitral Aortic valve Aortic Heart Valves

Groundbreaking Data in Interventional Cardiology to be Featured at Society for Cardiovascular Angiology and Interventions SCAI 2024 Scientific Sessions

DAIC

MAY 1, 2024

We believe the tools, resources, and information shared at the meeting will provide the healthcare community with greater expertise to improve patient outcomes and also connect with their interventional cardiology colleagues,” said SCAI President George D. Dangas, MD, PhD, MSCAI , Icahn School of Medicine - Mt.

Interventional Cardiology

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease

Redo-TAVR with balloon-expandable valves: outcomes from a national registry

Cardiology Update

NOVEMBER 26, 2023

In light of the growing number of patients undergoing transcatheter aortic valve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. No significant disparities were found in the rates of death at 30 days (4.7%

TAVR

TAVR Aortic valve Outcomes Aortic

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

DAIC

APRIL 9, 2024

It is also the first to focus specifically on informing device selection for patients with small aortic annuli, a patient group that is primarily women and has been underrepresented in previous clinical trials for TAVR. percentage points—in one-year bioprosthetic valve dysfunction favoring the Evolut platform.

TAVR

TAVR Aortic valve Aortic Anatomy

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses

Frontiers in Cardiovascular Medicine

DECEMBER 8, 2024

In patients undergoing transcatheter aortic valve implantation (TAVI), multi-valve disease is common and associated with worse outcomes. Despite multiple emerging transcatheter valve treatment options, no guidelines exist for the transcatheter treatment of multi-valve disease.

Bicuspid/Mitral

Bicuspid/Mitral Aortic Aortic valve Heart Valves

Patients Who Received Ross Procedure Demonstrate Excellent Survival Rates after 20 Years

Case Report: A case of transcatheter aortic valve replacement in a patient with a small aortic annulus using the Acurate Neo2

Predictors of permanent pacemaker requirement in aortic stenosis patients undergoing self-expanding valve transcatheter aortic valve replacement using the cusp overlap technique

Webinars

What Are the Implications of Choosing a TAVR-First Strategy in the Lifetime Management of Aortic Stenosis?: A Critical Review of TAVR-Explant- and Redo-TAVR

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

Direct aortic TAVI via anterior right mini-thoracotomy using 32 mm myval for pure aortic regurgitation

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

TAVI in Patients With High-Risk Symptomatic Native AR

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Novel Real-Time Fluoroscopic Assessment Method of Transcatheter Heart Valve Expansion Following Balloon-Expandable TAVR

Redo Transcatheter Aortic Valve Implantation in the Lotus Mechanically Expanded Transcatheter Heart Valve: Bench-Top Analysis, Clinical Experience, and Procedural Guidance

Time to TAVI: streamlining the pathway to treatment

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left?sided valvular heart disease in Europe. Insights from the ESC?EORP Valvular Heart Disease II survey

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

Triumph in TAVI: Adana ?ehir Sa?l?k Uygulama ve Ara?t?rma Merkezi Hosts Successful Masterclass with Prof. Dr. Ibrahim Halil Kurt

Triumph in TAVI: Adana City Health Training and Research Center Hosts Successful Masterclass with Prof. Dr. Ibrahim Halil Kurt

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

AHA Raises Awareness on HVD

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease

Groundbreaking Data in Interventional Cardiology to be Featured at Society for Cardiovascular Angiology and Interventions SCAI 2024 Scientific Sessions

Redo-TAVR with balloon-expandable valves: outcomes from a national registry

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

Published Research

Published Research

Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses

Stay Connected